Drugs / Pooled mesenchymal stem cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04184258 | Jul 2019 → Dec 2020 | systemic lupus erythematosus | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pooled mesenchymal stem cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04184258 ↗ |
| Modality | Cell therapy | “Pooled allogenic mesenchymal stem cell derived from olfactory mucosa” NCT04184258 ↗ |